Here, the underlying mechanism of the radiosensitization of afatinib is further explored, and we report that afatinib promotes radiosensitivity by reversing the EMT process via manipulating activity of the CD44-Stat3 axis in NPC cells. Here, CD44 is linked to nasopharyngeal carcinoma.